Darwin Global Management Ltd

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Darwin Global Management Ltd
CIK #0001839209
Sector Form 13F Holdings Value ($B)
Insmed Inc 2.6
Belite Bio Inc 0.5
Abivax Sa 0.4
Revolution Medicines Inc 0.2
Roivant Sciences Ltd 0.2
Magenta Therapeutics Inc 0.0
 
 
 
 
 
Holdings by Sector ($B)
5.04.03.02.01.00.02021202320252027
EDGAR Form CIK 2011 - 2026
13F-HR [0001839209]
3 [0001839209]
4 [0001839209]
SC 13D [0001839209]
SC 13G [0001839209]
Form 13D/13G Filer Form 13D/13G Subject Filed
Darwin Global Management Ltd Belite Bio Inc [2025-12-10]
Darwin Global Management Ltd Insmed Inc [2024-09-03]
Darwin Global Management Ltd TG Therapeutics Inc [2023-04-03]
Darwin Global Management Ltd Ambrx Biopharma Inc [2023-03-08]
Darwin Global Management Ltd Ambrx Biopharma Inc [2022-12-19]
Form 3/4/5 Subject 2011 - 2026
Darwin Global Management Limited
Trehan Abhishek
Ambrx Biopharma Cayman Inc
Darwin Global Master Fund Ltd
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Ambrx Biopharma Cayman Inc AMAM
"American Depository Shares (""ADSs"")" · derivative
2023-06-27 Buy 5,384,063 $13.93 74,999,998
Ambrx Biopharma Cayman Inc AMAM
ADSs · derivative
2023-03-06 Buy 3,615,000 $6.50 23,497,500
Ambrx Biopharma Cayman Inc AMAM
ADSs · derivative
2023-02-28 Buy 39,957 $6.02 240,541
Ambrx Biopharma Cayman Inc AMAM
"American Depository Shares (""ADSs"")" · derivative
2023-02-27 Buy 65,127 $5.48 356,896
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com